Venus Remedies joins AMR Industry Alliance to combat global health threat 

Venus Remedies has joined the league of over 100 globally renowned organisations as a member of the AMR Industry Alliance (AMRIA) in continuation of its commitment to develop solutions to combat the public health threat posed by antimicrobial resistance (AMR).

Welcoming Venus Remedies as a new member, Melissa Mitchell, Secretariat Lead, AMR Industry Alliance, said, “We are delighted to have Venus Remedies join our ranks. As an organisation, they lead by example and make commendable efforts to counter the threat of AMR by improving the access of AMR-relevant drugs to third-world countries and encouraging appropriate antibiotic use, along with good stewardship activities. Leading companies in the lifesciences sector, like Venus Remedies, are playing a vital role in the mitigation of AMR and continue to strengthen multi-stakeholder collaborations.”

Saransh Chaudhary, CEO, Venus Medicine Research Centre (VMRC), said in the statement, “It is an honour to collaborate with the global lifesciences industry under the aegis of the AMR Industry Alliance and devise sustainable solutions to AMR. I hope this association will amplify our existing efforts against AMR at a global level by shaping relevant AMR policies and plugging the leaks in the current antibiotic research and manufacturing landscape with focus on access and appropriate use.”